Eesti - eesti - Ravimiamet

viatris sia - kaltsiumnadropariin - süstelahus süstlis - 3800rÜ anti xa 0.4ml 0.4ml 2tk; 3800rÜ anti xa 0.4ml 0.4ml 10tk

Eesti - eesti - Ravimiamet

aspen pharma trading limited - kaltsiumnadropariin - süstelahus süstlis - 9500rÜ anti xa 1ml 1ml 10tk; 9500rÜ anti xa 1ml 1ml 2tk

Eesti - eesti - Ravimiamet

viatris sia - kaltsiumnadropariin - süstelahus süstlis - 2850rÜ anti xa 0.3ml 0.3ml 10tk; 2850rÜ anti xa 0.3ml 0.3ml 2tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - hulgiskleroos - selektiivsed immunosupressandid - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 30tk; 0,4mg+0,5mg 7tk; 0,4mg+0,5mg 90tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 90tk; 0,4mg+0,5mg 7tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosupressandid - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosuppressants, valikuline immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 28tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 84tk